DexCom
DXCM
$124.34
Share price
-9.91%
Change (1 day)
-0.47%
Change (1 year)
Categories
DexCom (DXCM) - Total assets
Total assets on the balance sheet as of December 2023 : $6.26 B
According to DexCom's latest financial reports the company's total assets are $6.26 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
DexCom - Total assets on balance sheet (from 2005 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $6.26 B | 16.19% |
| 2022-12-31 | $5.39 B | 9.29% |
| 2021-12-31 | $4.93 B | 14.98% |
| 2020-12-31 | $4.29 B | 79.14% |
| 2019-12-31 | $2.39 B | 25% |
| 2018-12-31 | $1.91 B | 111.92% |
| 2017-12-31 | $0.90 B | 124.45% |
| 2016-12-31 | $0.40 B | 37.95% |
| 2015-12-31 | $0.29 B | 58.18% |
| 2014-12-31 | $0.18 B | 50.69% |
| 2013-12-31 | $0.12 B | 15.57% |
| 2012-12-31 | $0.10 B | -12.03% |
| 2011-12-31 | $0.12 B | 56.16% |
| 2010-12-31 | $77.16 M | 64.36% |
| 2009-12-31 | $46.94 M | 6.99% |
| 2008-12-31 | $43.88 M | -43.2% |
| 2007-12-31 | $77.25 M | 19.68% |
| 2006-12-31 | $64.55 M | 13.8% |
| 2005-12-31 | $56.72 M | 93.22% |
| 2004-12-31 | $29.35 M | 41.37% |
| 2003-12-31 | $20.76 M | |
| 2001-12-31 | $8.64 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 2,574.72% | 🇺🇸 USA |
 Abbott Laboratories ABT | $73.21 B | 1,068.71% | 🇺🇸 USA |
 Medtronic MDT | $90.83 B | 1,350.01% | 🇮🇪 Ireland |
 Becton Dickinson BDX | $52.27 B | 734.45% | 🇺🇸 USA |
 Edwards Lifesciences EW | $9.36 B | 49.46% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | $0.95 B | -84.79% | 🇺🇸 USA |
 QuidelOrtho QDEL | $8.56 B | 36.69% | 🇺🇸 USA |
 West Pharmaceutical WST | $3.82 B | -38.87% | 🇺🇸 USA |